Bone health is critically influenced by the balance of growth hormone signalling, with both growth hormone deficiency (GHD) and acromegaly demonstrating significant but contrasting impacts on the ...

Phosphodiesterase 3 (PDE3) inhibitors are clinically approved drugs used for treating thrombosis, heart diseases, and asthma. Now, however, scientists have found that PDE3 inhibitors can also ...

Researchers have found that phosphodiesterase 3 (PDE3) inhibitors have the ability to boost long bone growth. Conventionally used to treat heart disease, thrombosis, and asthma, PDE3 inhibitors can ...

Loss of Dnmt1 disrupted normal DNA methylation in chondrocytes, leading to increased expression of genes involved in cellular energy metabolism. As a result, metabolic abnormalities occurred, ...

The global bone densitometer market is projected to grow at a rate of 4.5% by 2026. Key drivers of this expansion include the rising prevalence of osteoporosis and vitamin D deficiency, a growing ...

Dublin, Sept. 25, 2023 (GLOBE NEWSWIRE) -- The "Dual-Energy X-Ray Absorptiometry (DEXA) Market: Trends, Opportunities and Competitive Analysis 2023-2028" report has been added to ...